Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BITO vs GSK✓SelectedUSD · GSKBITO vs GSK performance historyLatest closeAs of-0.84%11/19
Stock and ETF performance explorer

BITO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-16.6%
GSK return
+39.6%
Excess return
-56.2%
Maximum drawdown
-74.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%-1.6%+0.7%-0.5%
7D-13.2%-4.7%-8.5%-12.3%
30D-25.0%-4.7%-20.3%-24.4%
3M-10.6%-8.8%-1.8%-9.1%
6M-20.7%-4.6%-16.1%-20.3%
YTD-31.4%+1.0%-32.3%-32.3%
1Y-33.1%+6.9%-40.0%-35.0%
3Y+40.9%+52.5%-11.7%+14.6%
5Y-16.6%+40.3%-56.9%-39.2%
All-16.6%+39.6%-56.2%-39.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling